Join
Live feed
·
INSIDERFilingvia Quantisnow
Rhythm Pharmaceuticals Inc. logo

Chief Financial Officer Smith Hunter C sold $708,576 worth of shares (7,071 units at $100.21), decreasing direct ownership by 6% to 118,466 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RYTM· Rhythm Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RYTM (Rhythm Pharmaceuticals Inc.) and more on Quantisnow.